GlassScriptPhysician profile
Ali M Sajadi
NPI 1326028614
$4,522.72
in general payments reported to CMS, 2019-2025
42 companies · $507 in 2025
The $507 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $647 · 2021: $1,137 · 2022: $1,031 · 2023: $275 · 2024: $47.43 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $724.58 | 2019-2022 | |
| Janssen Biotech, INC. | $580.50 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $314.18 | 2021-2023 | Prolaris |
| Urovant Sciences INC | $245.76 | 2022 | |
| Antares Pharma, INC. | $244.09 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Zimvie INC. | $217.23 | 2023-2025 | |
| Geistlich Pharma, North America, INC. | $208.92 | 2025 | Biomaterials |
| Allergan, INC. | $184.30 | 2019-2022 | |
| Axogen | $155.69 | 2025 | |
| Coloplast Corp | $143.48 | 2020-2022 | |
| Blue Earth Diagnostics | $108.08 | 2019-2022 | |
| Rochester Medical Corporation | $103.68 | 2019-2022 | |
| Abbott Laboratories | $95.69 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.07 | 2019-2023 | |
| Endo Pharmaceuticals INC. | $85.83 | 2019-2020 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Sajadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.